Source comparison
CJC-1295 No DAC Stability: Research vs Practical Comparison
2–8°C, amber vial, minimal access 12–14 days 90–95% Benzyl alcohol depletion after day 14 Optimal for multi-dose protocols. Supports twice-daily dosing for one week 2–8°C, clear vial, daily access 7–10 days 75–85% Light-induced oxidation + oxygen exposure Acce
This comparison does not assign a generated winner or score.
- 2–8°C, amber vial, minimal access
- 12–14 days
- 90–95%
- Benzyl alcohol depletion after day 14
- Optimal for multi-dose protocols. Supports twice-daily dosing for one week
- 2–8°C, clear vial, daily access
- 7–10 days
- 75–85%
- Light-induced oxidation + oxygen exposure
- Acceptable for short-term use. Pre-fill syringes to extend usability
- 8–15°C (standard fridge fluctuation)
- 5–7 days
- 60–75%
- Thermal aggregation accelerates
- Suboptimal. Invest in temperature-monitored storage or reduce batch size
- Room temperature (20–25°C)
- 24–48 hours
- <50% by day 3
- Rapid enzymatic and chemical degradation
- Emergency-only scenario. Peptide integrity cannot be verified visually
- Frozen post-reconstitution (−20°C)
- Not recommended
- Unpredictable
- Ice crystal formation disrupts peptide structure
- Freezing lyophilised powder is safe; freezing reconstituted solution is not